Novartis Ag (NVSEF) Property, Plant & Equipment (Net) Growth (5y) (2014 - 2025)

Novartis Ag (NVSEF) Property, Plant & Equipment (Net) Growth (5y) (2014 - 2025) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Novartis Ag	-	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2025	-2.54%
Jun 30, 2025	231.32%
Dec 31, 2024	18.47%
Jun 30, 2024	191.46%
Dec 31, 2023	28.50%
Jun 30, 2023	-7.47%
Dec 31, 2022	209.78%
Dec 31, 2021	32.76%
Dec 31, 2020	-5.16%
Jun 30, 2020	1,906.21%
Mar 31, 2020	1,906.21%
Dec 31, 2019	-14.91%
Dec 31, 2018	-3,272.72%
Dec 31, 2017	-14.90%
Dec 31, 2016	-18.61%
Dec 31, 2015	0.18%
Dec 31, 2014	2.58%